Phreesia stock declines following analyst downgrade

Phreesia, Inc. (PHR) shares experienced a decline following a series of analyst updates and recent quarterly earnings. The stock fell nearly 7% in a single session after Raymond James analyst John Ransom downgraded the company from 'outperform' to 'market perform' (hold).

Ransom cited concerns regarding declining organic revenue growth, which could potentially turn negative in the second half of the year. Additionally, the analyst noted that investments in artificial intelligence capabilities might pressure EBITDA growth, alongside potential budget constraints among healthcare provider clients.

Despite these headwinds, Phreesia reported a 10% year-over-year revenue increase and a nearly threefold increase in profitability in its recent quarter. Market sentiment remains mixed; while some firms like Canaccord Genuity Group and Needham & Company LLC maintain 'buy' ratings, the consensus among eighteen research firms is currently a 'hold'.